» Articles » PMID: 25203111

Infection with Host-range Mutant Adenovirus 5 Suppresses Innate Immunity and Induces Systemic CD4+ T Cell Activation in Rhesus Macaques

Overview
Journal PLoS One
Date 2014 Sep 10
PMID 25203111
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Ad5 is a common cause of respiratory disease and an occasional cause of gastroenteritis and conjunctivitis, and seroconversion before adolescence is common in humans. To gain some insight into how Ad5 infection affects the immune system of rhesus macaques (RM) 18 RM were infected with a host-range mutant Ad5 (Ad5hr) by 3 mucosal inoculations. There was a delay of 2 to 6 weeks after the first inoculation before plasmacytoid dendritic cell (pDC) frequency and function increased in peripheral blood. Primary Ad5hr infection suppressed IFN-γ mRNA expression, but the second Ad5hr exposure induced a rapid increase in IFN-gamma mRNA in peripheral blood mononuclear cells (PBMC). Primary Ad5hr infection suppressed CCL20, TNF and IL-1 mRNA expression in PBMC, and subsequent virus exposures further dampened expression of these pro-inflammatory cytokines. Primary, but not secondary, Ad5hr inoculation increased the frequency of CXCR3+ CD4+ T cells in blood, while secondary, but not primary, Ad5hr infection transiently increased the frequencies of Ki67+, HLADR+ and CD95+/CCR5+ CD4+ T cells in blood. Ad5hr infection induced polyfunctional CD4 and CD8+ T cells specific for the Ad5 hexon protein in all of the animals. Thus, infection with Ad5hr induced a complex pattern of innate and adaptive immunity in RM that included transient systemic CD4+ T cell activation and suppressed innate immunity on re-exposure to the virus. The complex effects of adenovirus infection on the immune system may help to explain the unexpected results of testing Ad5 vector expressing HIV antigens in Ad5 seropositive people.

Citing Articles

Pathogenicity of a novel bovine adenovirus type 3 with a natural deletion partial fiber gene in BALB/c mice.

Li Q, He S, Zou Y, Yue H, Tang C, Liu J Front Vet Sci. 2023; 10:1138159.

PMID: 37035797 PMC: 10076824. DOI: 10.3389/fvets.2023.1138159.


Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection.

Curtis 2nd A, Saha P, Dennis M, Berendam S, Ramasubramanian P, Cross K mSphere. 2022; 7(1):e0083921.

PMID: 35196125 PMC: 8865927. DOI: 10.1128/msphere.00839-21.


Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro.

Natale M, Minning T, Albareda M, Castro Eiro M, Alvarez M, Lococo B PLoS Negl Trop Dis. 2021; 15(6):e0009473.

PMID: 34061845 PMC: 8195349. DOI: 10.1371/journal.pntd.0009473.


Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.

Castro Eiro M, Natale M, Alvarez M, Shen H, Viotti R, Lococo B J Antimicrob Chemother. 2021; 76(6):1580-1592.

PMID: 33693664 PMC: 8600036. DOI: 10.1093/jac/dkab054.


Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Whittaker E, Lopez-Varela E, Broderick C, Seddon J Front Pediatr. 2019; 7:233.

PMID: 31294001 PMC: 6603259. DOI: 10.3389/fped.2019.00233.


References
1.
Klessig D, Grodzicker T . Mutations that allow human Ad2 and Ad5 to express late genes in monkey cells map in the viral gene encoding the 72K DNA binding protein. Cell. 1979; 17(4):957-66. DOI: 10.1016/0092-8674(79)90335-0. View

2.
Friedman J, Horwitz M . Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex. J Virol. 2002; 76(11):5515-21. PMC: 137041. DOI: 10.1128/jvi.76.11.5515-5521.2002. View

3.
Qureshi H, Ma Z, Huang Y, Hodge G, Thomas M, DiPasquale J . Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1.... J Virol. 2011; 86(4):2239-50. PMC: 3302390. DOI: 10.1128/JVI.06175-11. View

4.
Lesokhin A, Delgado-Lopez F, Horwitz M . Inhibition of chemokine expression by adenovirus early region three (E3) genes. J Virol. 2002; 76(16):8236-43. PMC: 155150. DOI: 10.1128/jvi.76.16.8236-8243.2002. View

5.
Evans A . Adenovirus infections in children and young adults; with comments on vaccination. N Engl J Med. 1958; 259(10):464-8. DOI: 10.1056/NEJM195809042591002. View